AXE 2.38% 21.5¢ archer materials limited

Ann: Biochip experiments begin to develop kidney disease testing, page-24

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 484 Posts.
    lightbulb Created with Sketch. 826
    I get that you're only speculating. And I would maintain that to say '...such as kidney disease,..' would have also highlighted that this is a well known biosensor field that many are in and we could have then realised where AXE was attempting to bring a solution. I don't think it would have been spruiking. Somehow, and I'm of course speculating, this was what I think was the final straw.

    I think I am more miffed that he demo-ed both 12CQ and bio chip to WEF. Would he have said the same there ? ' don't worry about what the chip will test for' ? Maybe he did. In which case, it amounts to nothing much in my book.
 
watchlist Created with Sketch. Add AXE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.